Pfg Investments, LLC Mereo Biopharma Group PLC Transaction History
Pfg Investments, LLC
- $1.65 Trillion
- Q1 2024
A detailed history of Pfg Investments, LLC transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Pfg Investments, LLC holds 31,200 shares of MREO stock, worth $117,624. This represents 0.01% of its overall portfolio holdings.
Number of Shares
31,200
Previous 30,000
4.0%
Holding current value
$117,624
Previous $69.3 Million
48.57%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding MREO
# of Institutions
88Shares Held
85.6MCall Options Held
182KPut Options Held
249K-
Rubric Capital Management LP New York, NY13.6MShares$51.1 Million1.52% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.33MShares$35.2 Million0.06% of portfolio
-
Mangrove Partners New York, NY8.75MShares$33 Million3.09% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD8.14MShares$30.7 Million0.7% of portfolio
-
683 Capital Management, LLC New York, NY5.75MShares$21.7 Million1.62% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $471M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...